Literature DB >> 10484948

Competence of depressed patients for consent to research.

P S Appelbaum1, T Grisso, E Frank, S O'Donnell, D J Kupfer.   

Abstract

OBJECTIVE: The capacities of depressed patients to consent to research have been questioned by commentators who fear that the cognitive effects of a disorder may impair subjects' abilities to protect their interests. This study used a new instrument for assessing depressed patients' capacities to consent to research and examined their performance, including the relation between severity of depression and extent of impairment.
METHOD: Twenty-six female outpatients with major depression (assessed with the Schedule of Affective Disorders and Schizophrenia-Lifetime Version) enrolled in a study of maintenance psychotherapy were recruited for this project. Consent-related abilities were measured with the MacArthur Competence Assessment Tool-Clinical Research (MacCAT-CR) 1 week after intake and again 8-10 weeks later. Depressive symptoms were measured by the Hamilton Depression Rating Scale.
RESULTS: Almost all subjects performed quite well on the capacity measures and maintained that level of performance over time. There was no correlation between performance and degree of depressive symptoms and little relation to prior research experience. Some subjects appeared confused about the extent to which decisions about assignment to treatment groups would be made on the basis of their clinical condition rather than randomly.
CONCLUSIONS: This outpatient group with major depression showed few impairments in their decision-making capacities related to research. As in other studies, some concerns were raised about subjects' appreciation that treatment assignments would not be individualized for their needs. Examination of hospitalized patients and those with psychotic depression would help to determine whether they show greater degrees of impairment. The MacCAT-CR was easily adapted for use with this depressed group.

Entities:  

Keywords:  Biomedical and Behavioral Research; Empirical Approach; Mental Health Therapies; Western Psychiatric Institute and Clinic (Pittsburgh, PA)

Mesh:

Year:  1999        PMID: 10484948     DOI: 10.1176/ajp.156.9.1380

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  55 in total

Review 1.  Ethical considerations in psychopharmacological research involving decisionally impaired subjects.

Authors:  Donald L Rosenstein; Franklin G Miller
Journal:  Psychopharmacology (Berl)       Date:  2003-05-28       Impact factor: 4.530

Review 2.  Beyond the question of placebo controls: ethical issues in psychopharmacological drug studies.

Authors:  Ellen Frank; Danielle M Novick; David J Kupfer
Journal:  Psychopharmacology (Berl)       Date:  2003-04-30       Impact factor: 4.530

3.  End-of-life care and mental illness: a model for community psychiatry and beyond.

Authors:  Philip J Candilis; Mary Ellen G Foti; Jacob C Holzer
Journal:  Community Ment Health J       Date:  2004-02

4.  Capacity to make medical treatment decisions in multiple sclerosis: a potentially remediable deficit.

Authors:  Michael R Basso; Philip J Candilis; Jay Johnson; Courtney Ghormley; Dennis R Combs; Taeh Ward
Journal:  J Clin Exp Neuropsychol       Date:  2010-12       Impact factor: 2.475

Review 5.  Evidence-based ethics for neurology and psychiatry research.

Authors:  Scott Y H Kim
Journal:  NeuroRx       Date:  2004-07

Review 6.  Emerging empirical evidence on the ethics of schizophrenia research.

Authors:  Laura B Dunn; Philip J Candilis; Laura Weiss Roberts
Journal:  Schizophr Bull       Date:  2005-10-19       Impact factor: 9.306

7.  Integrating Decision Making and Mental Health Interventions Research: Research Directions.

Authors:  Celia E Wills; Margaret Holmes-Rovner
Journal:  Clin Psychol (New York)       Date:  2006

8.  A direct comparison of research decision-making capacity: schizophrenia/schizoaffective, medically ill, and non-ill subjects.

Authors:  Philip J Candilis; Kenneth E Fletcher; Cynthia M A Geppert; Charles W Lidz; Paul S Appelbaum
Journal:  Schizophr Res       Date:  2008-02       Impact factor: 4.939

9.  Deep-brain stimulation for depression.

Authors:  Walter Glannon
Journal:  HEC Forum       Date:  2008-12

10.  Neuropsychological correlates of capacity determinations in Alzheimer disease: implications for assessment.

Authors:  Barton W Palmer; Kerry A Ryan; H Myra Kim; Jason H Karlawish; Paul S Appelbaum; Scott Y H Kim
Journal:  Am J Geriatr Psychiatry       Date:  2013-01-11       Impact factor: 4.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.